RALES
发表于 2025-3-23 12:18:46
Mammalian Targets of Rapamycin Inhibitors: Temsirolimus and Everolimus,ism; the mTOR pathway appears to be deregulated in a number of human malignancies including renal cell carcinoma..To date, two mTOR inhibitors have been registered for the treatment of renal cell carcinoma: temsirolimus (for treatment-naïve patients with poor prognostic features) and everolimus (for
concubine
发表于 2025-3-23 17:51:12
http://reply.papertrans.cn/83/8270/826987/826987_12.png
Ascendancy
发表于 2025-3-23 19:48:07
http://reply.papertrans.cn/83/8270/826987/826987_13.png
暴发户
发表于 2025-3-23 23:06:08
Forthcoming Drugs for Metastatic Renal Cell Carcinoma Therapy,t of advanced renal cell carcinoma (RCC). However, in most cases, RCC cells eventually develop drug resistance or drug treatments are stopped because of their adverse events (AEs)..TKIs that are selective for targeted molecules have potent antitumor effects and produce few side effects are ideal. Al
Hyperplasia
发表于 2025-3-24 03:12:18
http://reply.papertrans.cn/83/8270/826987/826987_15.png
是比赛
发表于 2025-3-24 09:32:05
http://reply.papertrans.cn/83/8270/826987/826987_16.png
cumber
发表于 2025-3-24 14:04:56
http://reply.papertrans.cn/83/8270/826987/826987_17.png
SOW
发表于 2025-3-24 14:53:22
http://reply.papertrans.cn/83/8270/826987/826987_18.png
DRAFT
发表于 2025-3-24 21:57:34
http://reply.papertrans.cn/83/8270/826987/826987_19.png
intercede
发表于 2025-3-25 00:33:49
http://reply.papertrans.cn/83/8270/826987/826987_20.png